Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
Alzheimer’s disease (AD), a progressively fatal neurodegenerative disorder, is the most prominent form of dementia found today. Patients suffering from Alzheimer’s begin to show the signs and symptoms, like decline in memory and cognition, long after the cellular damage has been initiated in their b...
Main Authors: | Mugdha Agarwal, Mohammad Rizwan Alam, Mohd Kabir Haider, Md. Zubbair Malik, Dae-Kwang Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/11/1/59 |
Similar Items
-
The Major Hypotheses of Alzheimer’s Disease: Related Nanotechnology-Based Approaches for Its Diagnosis and Treatment
by: César Cáceres, et al.
Published: (2023-11-01) -
Nanotechnology-Driven Therapeutic Innovations in Neurodegenerative Disorders: A Focus on Alzheimer’s and Parkinson’s Disease
by: Antea Krsek, et al.
Published: (2024-04-01) -
Nanotechnology for tau pathology in Alzheimer's disease
by: Rongrong Ma, et al.
Published: (2024-08-01) -
Body Fluid Biomarkers for Alzheimer’s Disease—An Up-To-Date Overview
by: Adrian Florian Bălașa, et al.
Published: (2020-10-01) -
Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease
by: Kate L. Jordan, et al.
Published: (2022-05-01)